| |
N = 109
|
|---|
|
Patient characteristics
|
n
|
mean (SD)
|
|---|
|
Sex (male/female)
|
54/55
| |
|
Age (years)
| |
52.8 (14.2)
|
|
Duration of spasticity symptoms (years)
|
|
1–5 years
|
21
| |
|
6–10 years
|
21
| |
|
11–15 years
|
16
| |
|
> 15 years
|
51
| |
|
Genetic defect
|
57
| |
|
SPG-3a
|
4
| |
|
SPG-4
|
36
| |
|
SPG-5a
|
2
| |
|
SPG-7
|
3
| |
|
SPG-8
|
3
| |
|
SPG-10
|
2
| |
|
SPG-17
|
1
| |
|
SPG-31
|
5
| |
|
SPG-72
|
1
| |
|
Positive family history
|
|
First degree relatives
|
83
| |
|
Other family members
|
47
| |
|
First degree relatives and/or other family members
|
90
| |
|
Unknown
|
8
| |
|
No
|
11
| |
|
Non-neurological comorbidities
|
|
Asthma/COPD
|
6
| |
|
Diabetes
|
1
| |
|
Hypertension
|
9
| |
|
Joint disorders*
|
13
| |
|
Cardiac problems
|
4
| |
|
Other non-neurological comorbidities
|
7
| |
- *Rheumatism and osteoarthritis were given as examples to participants. Patients were instructed that this category did not include non-specific back complaints
